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Summary and Guidance regarding the Genetic Information Nondiscrimination Act of 2008 (GINA)
Exceptions to GINA for Health Coverage GINA's provisions prohibiting discrimination in health coverage based on genetic information do not extend to life insurance, disability insurance, or long-term care insurance. For example:
 GINA does not make it illegal for a life insurance company to discriminate based on genetic information.  GINA's provisions prohibiting discrimination by employers based on genetic information generally do not apply to employers with fewer than 15 employees.  For health coverage provided by a health insurer to individuals, GINA does not prohibit the health insurer from determining eligibility or premium rates for an individual based on the manifestation of a disease or disorder in that individual.  For employment-based health coverage provided by group health plans, GINA permits the overall premium rate for an employer to be increased because of the manifestation of a disease or disorder of an individual enrolled in the plan, but the manifested disease or disorder of one individual cannot be used as genetic information about other group members to further increase the premium.  GINA also does not prohibit health insurers or health plan administrators from obtaining and using genetic test results in making payment determinations
Exception to GINA for Research by Health Insurers and Group Plans
The following information does not typically apply to the type of research that is conducted at the University of Kentucky (UK); however it does apply to collect genetic information on behalf of a group health plan or health insurers.
GINA includes a "research exception" to the general prohibition against health insurers or group health plans requesting that an individual undergo a genetic test. This exception allows health insurers and group health plans engaged in research to request (but not require) that an individual undergo a genetic test. One example of this would be if UK HMO wanted to conduct a research protocol to estimate its future expenses for a certain medical condition based on genetic information. The exception permits the request to be made but imposes the following requirements:
 The request must be made pursuant to research that complies with DHHS regulations at 45 CFR Part 46, or equivalent Federal regulations, and any applicable state or local laws for the protection of human subjects in research;  There must be clear indication that participation is voluntary and that noncompliance has no effect on enrollment or premiums or contribution amounts;  No genetic information collected or acquired as part of the research may be used for underwriting purposes;  The health insurer or group health plan must notify the Federal government in writing that it is conducting activities pursuant to this research exception and provide a description of the activities conducted; and  The health insurer or group health plan must comply with any future conditions that the Federal government may require for activities conducted under this research exception.
IRB Review and Informed Consent in Studies Involving Genetic Information
When investigators develop, and IRBs review, consent processes and documents for genetic research, they must consider the protections provided by GINA, particularly with respect to the following elements of informed consent that are required to be provided to subjects [unless an IRB has approved an alteration or waiver of these requirements in accordance with the requirements of HHS regulations at 45 CFR 46.116(c) 
or (d)]:
 A description of any reasonably foreseeable risks or discomforts to the subjects (45 CFR 46.116(a)(2)); and  A statement describing the extent, if any, to which confidentiality of records identifying the subject will be maintained (45 CFR 46.116(a)(5)).
